SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-020292
Filing Date
2020-07-23
Accepted
2020-07-23 21:25:53
Documents
1
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3121
  Complete submission text file 0000899243-20-020292.txt   4858
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Issuer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210
Business Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 (617) 951-5372
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Reporting) CIK: 0001787092 (see all company filings)

State of Incorp.: E9
Type: 3 | Act: 34 | File No.: 001-39398 | Film No.: 201044898